论文部分内容阅读
目的研究散发性戊型肝炎(HE)患者病毒血症、粪便排病毒及抗体消长规律。方法采用逆转录套式聚合酶链反应(RTnestedPCR)动态检测血清和粪便HEVRNA,采用HEVORF2、ORF3合成多肽单独和联合EIA法动态检测血清抗HEV。结果血清HEVRNA阳性患者占71%(44/62),平均持续时间为病后20.6天(全程随访32例);粪便HEVRNA阳性标本中有96.2%(25/26)出现在病后20天内;血清抗HEVIgM和IgG阳性率于发病半月内分别为71.1%(32/45)和97.8%(44/45),随病程的延长IgM较早阴转。结论病毒血症和粪便排病毒主要出现在急性早期;联合检测ORF2和ORF3抗体可提高EIA试验的敏感性,抗HEVIgM的特异性好而抗HEVIgG的灵敏度高
Objective To study the viremia, stool virus and antibody growth and development in patients with sporadic hepatitis E (HE). Methods The serum and fecal HEV RNA were detected by reverse transcription-nested-polymerase chain reaction (RT-PCR). HEVORF2 and ORF3 synthetic peptides were used to detect serum anti-HEV separately and in combination with EIA. Results Serum HEV RNA positive patients accounted for 71% (44/62), the average duration of 20.6 days after disease (32 cases were followed up); stool HEV RNA positive specimens in 96.2% (25/26) Within 20 days, the positive rates of anti-HEV IgM and IgG were 71.1% (32/45) and 97.8% (44/45) in the first half of the disease, respectively. Conclusions Viremia and staphylococcal virus occur mainly in early acute phase. Combined detection of ORF2 and ORF3 antibodies can increase the sensitivity of EIA test. The specificity of anti- HEVIgM is good and the sensitivity of HEVIgG is high